⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Man

DrugsSource: FDA (drug) · Date: 2026-09-09

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Baxter Healthcare

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Baxter Healthcare Corporation
Product
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50.
Reason / hazard
CGMP Deviations
Classification
Class II
Status
Ongoing
Distribution / sold at
US Nationwide; Puerto Rico; and Chile.
Recall initiated
2026-08-06
Code info
Lot # NC194075, Exp Date: 10/29/2027.
Product quantity
N/A
Voluntary mandated
Voluntary: Firm initiated
City
Deerfield
State
IL
Country
United States
Event id
99500
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.